Clinical trial
Efficacy and Safety of S18986 in the Treatment of Mild Cognitive Impairment…
NCT00202540 · Institut de Recherches Internationales Servier, Other · Terminated
Key facts
| NCT number | NCT00202540 |
|---|---|
| Title | Efficacy and Safety of S18986 in the Treatment of Mild Cognitive Impairment Patients |
| Official title | Efficacy of 15 mg and 50 mg of S18986 on Cognitive Symptoms in Mild Cognitive Impairment Patients Treated Over a 12-month Oral Administration Period |
| Lead sponsor | Institut de Recherches Internationales Servier, Other |
| Status | Terminated |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Mild Cognitive Impairment |
| Intervention type | Drug |
| Interventions | S18986 |
| Enrollment | 38 |
| Start date | Jun 1, 2005 |
| Primary completion | Mar 29, 2006 |
| Completion | Mar 29, 2006 |
| First posted | Sep 20, 2005 |
| Last update posted | Jul 25, 2024 |
| Countries | France |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: